Frequently asked questions

A compounded medication is prepared for an individual patient by a licensed pharmacy. These medications are not FDA-approved, which means the FDA does not review them for safety, effectiveness, or quality in the same way as approved drugs.

GLP-1 medications are usually delivered as a subcutaneous injection, which means the medication goes just under the skin rather than into a vein or muscle. Many patients find the routine manageable after the first few doses, and an injection guide is typically provided with the program.

Availability depends on the provider network. The underlying Enhance program currently notes broad multi-state access, but coverage can still change, so the safest next step is to confirm state availability during intake or with support before assuming eligibility.

Program materials commonly reference a BMI threshold of 25 or higher for new GLP-1 patients, with lower thresholds sometimes used for current or recent maintenance patients. Final eligibility is always determined by an independent licensed provider after reviewing your medical history.

StartEnhance itself is an educational and referral site, and any medical intake, payment, or treatment data is handled inside the provider workflow rather than by this website. Provider-facing programs generally frame their systems around encrypted payment processing, HIPAA-aware medical storage, and limited visibility into stored payment details.

The provider-facing program materials list major credit cards such as Visa, Mastercard, Discover, and American Express. FSA or HSA acceptance may be limited, so visitors should verify that directly before they assume reimbursement or card eligibility.

StartEnhance is a referral and education website built to explain semaglutide, tirzepatide, and GLP-1 + GIP program options before a visitor moves into provider review. It does not diagnose, prescribe, or ship medication.

For this site, use support@startenhance.com. For provider-side questions about ongoing treatment, shipping status, or account access, the current support line published for the underlying program is 1-888-299-5088.

The published program structure highlights access to wellness coaching, nutrition guidance, and exercise support through the member experience. The exact scope depends on the provider-side program and how your care team sets up your plan.

Once a prescription is approved and released to the pharmacy workflow, published program timelines typically reference delivery within about 5 to 7 business days, though timing can vary by location and pharmacy processing.

Program materials currently describe a full refund before the prescription is processed by the pharmacy and a refund if a provider determines you are ineligible during onboarding. Once medication has been processed or shipped, refund options may be limited.

Start with the filter that matters most to you: lower-cost semaglutide, stronger tirzepatide support, a premium combined offer, or lower-dose microdosing. From there, compare the program page, the FAQ, and the how-it-works overview before deciding whether to continue into intake.